Marcin Pasiarski

Kielce, SK 25734, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Exploring the Significance of Immune Checkpoints and EBV Reactivation in Antibody Deficiencies with Near-Normal Immunoglobulin Levels or Hyperimmunoglobulinemia.

Exploring the Significance of Immune Checkpoints and EBV Reactivation in Antibody Deficiencies with Near-Normal Immunoglobulin Levels or Hyperimmunoglobulinemia.

Journal: Cancers
Published: August 15, 2023

Could Immune Checkpoint Disorders and EBV Reactivation Be Connected in the Development of Hematological Malignancies in Immunodeficient Patients?

Could Immune Checkpoint Disorders and EBV Reactivation Be Connected in the Development of Hematological Malignancies in Immunodeficient Patients?

Journal: Cancers
Published: August 10, 2023

Immune Checkpoint Pathway Expression in Lymphocyte Subpopulations in Patients with Common Variable Immunodeficiency and Chronic Lymphocytic Leukemia.

Immune Checkpoint Pathway Expression in Lymphocyte Subpopulations in Patients with Common Variable Immunodeficiency and Chronic Lymphocytic Leukemia.

Journal: Cancers
Published: August 06, 2023

Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis.

Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis.

Journal: Journal of clinical medicine
Published: December 31, 2021

Expression of CTLA-4 and CD86 Antigens and Epstein-Barr Virus Reactivation in Chronic Lymphocytic Leukemia-Any Link with Known Prognostic Factors?

Expression of CTLA-4 and CD86 Antigens and Epstein-Barr Virus Reactivation in Chronic Lymphocytic Leukemia-Any Link with Known Prognostic Factors?

Journal: Cancers
Published: December 03, 2021

Toll-like Receptor 2 as a Marker Molecule of Advanced Ovarian Cancer.

Toll-like Receptor 2 as a Marker Molecule of Advanced Ovarian Cancer.

Journal: Biomolecules
Published: June 24, 2021

Immunological Prognostic Factors in Multiple Myeloma.

Immunological Prognostic Factors in Multiple Myeloma.

Journal: International journal of molecular sciences
Published: February 08, 2021

Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review.

Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review.

Journal: Cells
Published: August 27, 2020

CAR-T Cell Therapy-An Overview of Targets in Gastric Cancer.

CAR-T Cell Therapy-An Overview of Targets in Gastric Cancer.

Journal: Journal of clinical medicine
Published: May 15, 2020

Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy.

Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy.

Journal: Cells
Published: March 07, 2020

Collection of umbilical cord blood and the risk of complications in postpartum women after natural labour in the context of the possibility of umbilical cord stem cells usage in clinical practice.

Collection of umbilical cord blood and the risk of complications in postpartum women after natural labour in the context of the possibility of umbilical cord stem cells usage in clinical practice.

Journal: Ginekologia polska
Published: March 03, 2020

Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium.

Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium.

Journal: Leukemia & lymphoma
Published: November 21, 2019
Showing 1-12 of 31

Last Updated: 09/26/2026